Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-28

FDA Approved: NORETHINDRONE AND ETHINYL ESTRADIOL — Original Application (Naari Pte Limited)

View source ↗

Summary

FDA approves the original application for norethindrone and ethinyl estradiol as a generic oral contraceptive by Naari Pte Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORETHINDRONE AND ETHINYL ESTRADIOL (NORETHINDRONE AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for NORETHINDRONE AND ETHINYL ESTRADIOL (NORETHINDRONE AND ETHINYL ESTRADIOL)